FIGURE 1.
FIGURE 1.
ROI drawings are displayed on coronal (A and B) and left sagittal (C and D) MR images of a representative FAD subject (FAD-1). (A) Hippocampus (1), entorhinal cortex (2), superior temporal gyrus (3). (B) Ventricles (4), whole brain (5). (C) Posterior cingulate cortex (6). (D) Inferior parietal lobe (7). Left medial temporal lobe is shown magnified in A to highlight hippocampal (1) and entorhinal cortex (2) ROIs.
In this issue
Related Articles
Cited By...
- Donor-Specific Transcriptomic Analysis of Alzheimer's Disease-Associated Hypometabolism Highlights a Unique Donor, Ribosomal Proteins and Microglia
- 18F-FDG-PET Hyperactivity in Alzheimers Disease Cerebellum and Primary Olfactory Cortex
- Plasma metabolomics of presymptomatic PSEN1-H163Y mutation carriers: A pilot study
- Donor specific transcriptomic analysis of Alzheimers disease associated hypometabolism highlights a unique donor, microglia, and ribosomal proteins
- Aerobic Glycolysis in the Frontal Cortex Correlates with Memory Performance in Wild-Type Mice But Not the APP/PS1 Mouse Model of Cerebral Amyloidosis
- Cerebral perfusion alterations and cerebral amyloid in autosomal dominant Alzheimer disease
- Regional Neuronal Network Failure and Cognition in Late-Onset Sporadic Alzheimer Disease
- Altered Spontaneous Brain Activity in Type 2 Diabetes: A Resting-State Functional MRI Study
- Whither the Hippocampus? FDG-PET Hippocampal Hypometabolism in Alzheimer Disease Revisited
- Neurovascular Dysfunction and Faulty Amyloid {beta}-Peptide Clearance in Alzheimer Disease
- Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease
- Age-Related Metabolic Profiles in Cognitively Healthy Elders: Results from a Voxel-Based [18F]Fluorodeoxyglucose-Positron-Emission Tomography Study with Partial Volume Effects Correction
- Combining MR Imaging, Positron-Emission Tomography, and CSF Biomarkers in the Diagnosis and Prognosis of Alzheimer Disease
- Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease
- Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease
- Longitudinal multimodal imaging in mild to moderate Alzheimer disease: a pilot study with memantine
- Altered fMRI activation during mental rotation in those at genetic risk for Alzheimer disease
- Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias
- Comparison of 18F-FDG PET and Optimized Voxel-Based Morphometry for Detection of Alzheimer's Disease: Aging Effect on Diagnostic Performance
- Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism
- 18F-FDG PET Database of Longitudinally Confirmed Healthy Elderly Individuals Improves Detection of Mild Cognitive Impairment and Alzheimer's Disease